Literature DB >> 22534620

Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers.

Douglas L Mann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22534620      PMCID： PMC4538946          DOI： 10.1161/CIRCULATIONAHA.112.107797

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   39.918


× No keyword cloud information.
  18 in total

Review 1.  Translational aspects of sphingosine 1-phosphate biology.

Authors:  Susan Pyne; Nigel J Pyne
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

2.  Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate.

Authors:  L C Boujaoude; C Bradshaw-Wilder; C Mao; J Cohn; B Ogretmen; Y A Hannun; L M Obeid
Journal:  J Biol Chem       Date:  2001-07-06       Impact factor: 5.157

3.  A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model.

Authors:  Shifeng Pan; Yuan Mi; Charles Pally; Christian Beerli; Alice Chen; Danilo Guerini; Klaus Hinterding; Barbara Nuesslein-Hildesheim; Tove Tuntland; Sophie Lefebvre; Yi Liu; Wenqi Gao; Alan Chu; Volker Brinkmann; Christian Bruns; Markus Streiff; Catherine Cannet; Nigel Cooke; Nathanael Gray
Journal:  Chem Biol       Date:  2006-11

Review 4.  Sphingosine-1-phosphate signaling and its role in disease.

Authors:  Michael Maceyka; Kuzhuvelil B Harikumar; Sheldon Milstien; Sarah Spiegel
Journal:  Trends Cell Biol       Date:  2011-10-14       Impact factor: 20.808

Review 5.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

6.  Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro.

Authors:  S Kapadia; G Torre-Amione; T Yokoyama; D L Mann
Journal:  Am J Physiol       Date:  1995-02

7.  The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Petra Keul; Markus Tölle; Susann Lucke; Karin von Wnuck Lipinski; Gerd Heusch; Mirjam Schuchardt; Markus van der Giet; Bodo Levkau
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-07       Impact factor: 8.311

Review 8.  Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system.

Authors:  Mirjam Schuchardt; Markus Tölle; Jasmin Prüfer; Markus van der Giet
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

9.  FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.

Authors:  E Eroume A Egom; Yunbo Ke; Hanny Musa; Tamer M A Mohamed; Tao Wang; Elizabeth Cartwright; R John Solaro; Ming Lei
Journal:  J Mol Cell Cardiol       Date:  2009-10-21       Impact factor: 5.000

10.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094
View more
  5 in total

1.  Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction.

Authors:  Yoav Hadas; Adam S Vincek; Elias Youssef; Magdalena M Żak; Elena Chepurko; Nishat Sultana; Mohammad Tofael Kabir Sharkar; Ningning Guo; Rinat Komargodski; Ann Anu Kurian; Keerat Kaur; Ajit Magadum; Anthony Fargnoli; Michael G Katz; Nadia Hossain; Ephraim Kenigsberg; Nicole C Dubois; Eric Schadt; Roger Hajjar; Efrat Eliyahu; Lior Zangi
Journal:  Circulation       Date:  2020-01-29       Impact factor: 29.690

2.  Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts.

Authors:  SiddabasaveGowda B Gowda; Divyavani Gowda; Vasundhara Kain; Hitoshi Chiba; Shu-Ping Hui; Charles E Chalfant; Vibhu Parcha; Pankaj Arora; Ganesh V Halade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-20       Impact factor: 4.733

3.  U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: a prospective cohort study.

Authors:  Yanbo Xue; Wei Jiang; Qiong Ma; Xiqiang Wang; Pu Jia; Qiang Li; Shuping Chen; Bingxue Song; Ya Wang; Jingwen Zhang; Jing Liu; Guodong Yang; Yuyao Lin; Jing Liu; Linyan Wei; Caijuan Dong; Haiquan Li; Zhonglei Xie; Ling Bai; Aiqun Ma
Journal:  Lipids Health Dis       Date:  2020-06-04       Impact factor: 3.876

Review 4.  mRNA - A game changer in regenerative medicine, cell-based therapy and reprogramming strategies.

Authors:  Oleksandra Chabanovska; Anne-Marie Galow; Robert David; Heiko Lemcke
Journal:  Adv Drug Deliv Rev       Date:  2021-10-13       Impact factor: 17.873

5.  Sphingosine-1-Phosphate Signaling Regulates Myogenic Responsiveness in Human Resistance Arteries.

Authors:  Sonya Hui; Andrew S Levy; Daniel L Slack; Marcus J Burnstein; Lee Errett; Daniel Bonneau; David Latter; Ori D Rotstein; Steffen-Sebastian Bolz; Darcy Lidington; Julia Voigtlaender-Bolz
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.